Carcinoid syndrome epidemiology and demographics: Difference between revisions
(→Age) |
|||
| Line 19: | Line 19: | ||
*Females are more commonly affected with carcinoid syndrome than males. | *Females are more commonly affected with carcinoid syndrome than males. | ||
*Males are more commonly affected with thymic carcinoid tumor than females. The male to female ratio is approximately 3 to 1.<ref> Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour</ref> | *Males are more commonly affected with thymic carcinoid tumor than females. The male to female ratio is approximately 3 to 1.<ref> Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour</ref> | ||
===Race=== | |||
Carcinoid syndrome usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop carcinoid syndrome.<ref name="pmid15213627">{{cite journal| author=Maggard MA, O'Connell JB, Ko CY| title=Updated population-based review of carcinoid tumors. | journal=Ann Surg | year= 2004 | volume= 240 | issue= 1 | pages= 117-22 | pmid=15213627 | doi= | pmc=PMC1356383 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15213627 }} </ref> | |||
==References== | ==References== | ||
Revision as of 17:31, 29 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics |
|
Carcinoid syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately 2 per 100,000 individuals worldwide. The median age at diagnosis is 60.9 years.
Epidemiology and Demographics
Incidence
- The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide.[1]
- Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
- Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
- Ovarian carcinoid tumors account for 0.3% of all ovarian tumors and 0.5% of carcinoid tumors.[2]
Age
- Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women.
- The median age at diagnosis is 60.9 years.[3]
Gender
- Females are more commonly affected with carcinoid syndrome than males.
- Males are more commonly affected with thymic carcinoid tumor than females. The male to female ratio is approximately 3 to 1.[4]
Race
Carcinoid syndrome usually affects individuals of the Caucasian race. African American, Latin American, and Asian individuals are less likely to develop carcinoid syndrome.[3]
References
- ↑ Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
- ↑ Ovarian carcinoid tumors. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/ovarian-carcinoid-tumours
- ↑ 3.0 3.1 Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
- ↑ Thymic carcinoid tumour. Dr Aditya Shetty and Dr Yuranga Weerakkody et al. Radiopaedia 2015. http://radiopaedia.org/articles/thymic-carcinoid-tumour